Upgrade to SI Premium - Free Trial

Tevogen Bio (TVGN)

9.70 +0.55 (6.01%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/25 *Est.)

Latest Headlines

Form S-3 Tevogen Bio Holdings June 12, 2026 5:00 PM - SEC Filing Tevogen pursues acquisitions targeting $100 million annual revenue May 28, 2026 12:45 PM - StreetInsider Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue May 28, 2026 12:30 PM - Globe NewsWire Tevogen reports 51% reduction in operational losses for 2025 May 18, 2026 12:15 PM - StreetInsider Letter to Shareholders from CEO Dr. Ryan Saadi May 18, 2026 12:15 PM - Globe NewsWire Form 10-Q Tevogen Bio Holdings For: Mar 31 May 15, 2026 5:02 PM - SEC Filing Tevogen Bio secures $3 million PIPE financing from existing investor May 12, 2026 11:46 AM - StreetInsider Form 10-K/A Tevogen Bio Holdings For: Dec 31 April 30, 2026 5:01 PM - SEC Filing Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal April 27, 2026 11:50 AM - Globe NewsWire Form 8-K Tevogen Bio Holdings For: Apr 16 April 22, 2026 5:15 PM - SEC Filing Form 10-K Tevogen Bio Holdings For: Dec 31 March 31, 2026 5:16 PM - SEC Filing Tevogen Bio evaluates CRO acquisition worth over $20 million annually March 26, 2026 12:48 PM - StreetInsider Form 424B3 Tevogen Bio Holdings March 25, 2026 5:10 PM - SEC Filing Form 8-K Tevogen Bio Holdings For: Mar 20 March 25, 2026 5:05 PM - SEC Filing Tevogen Bio regains Nasdaq compliance after stock price recovery March 25, 2026 2:21 PM - StreetInsider Full Article List